Update on antiretroviral treatment during primary HIV infection. - Wikidata - awgldk - TriplyDB

Update on antiretroviral treatment during primary HIV infection.

Update on antiretroviral treatment during primary HIV infection.

http://www.wikidata.org/entity/Q38209874

about

Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012)Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering.Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.Screening for acute HIV infection in community-based settings: Cost-effectiveness and impact on transmissions.Tyrosine kinase inhibitors: potential use and safety considerations in HIV-1 infection.Neurological involvement in patients with acute/recent HIV-1 infection. A case-control study.Potential role of tyrosine kinase inhibitors during primary HIV-1 infection.Comment on: Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection.Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells.Phenotype, Polyfunctionality, and Antiviral Activity of Stimulated CD8 T-Cells From HIV Subjects Who Initiated cART at Different Time-Points After Acute Infection

P2860

Q28547790-CF576C83-EA43-412D-8341-E82B780B98EB Q35868716-A9261B12-61D8-439E-89AE-C26CBB7F6BD7 Q38538043-924404FD-5DA8-4571-9B2B-C680ACE5086B Q39070385-56B01207-BA67-4657-9561-D1D106864803 Q39226064-4BD65840-6495-49FD-B092-B3FA8AF606B6 Q40118949-D54CEB8D-2E69-47E2-B880-66F05BD39C80 Q40283574-169497DE-F9F0-4AE7-9EFA-BCC0D2668650 Q40345743-4385069D-544D-4B84-98ED-629EB28885B9 Q54209535-5467F5AF-FC64-48DA-8F55-63F4602A8CAA Q58572549-D9254E7F-D13D-46EC-A31E-36FE8251F922

P2860

Update on antiretroviral treatment during primary HIV infection.

http://www.wikidata.org/entity/Q38209874

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Update on antiretroviral treatment during primary HIV infection.

@en

type

label

Update on antiretroviral treatment during primary HIV infection.

@en

prefLabel

Update on antiretroviral treatment during primary HIV infection.

@en

P1433

Q38209874-8B80280F-802E-4F7E-8AE3-5E9BD431AEC8

P1476

Q38209874-1F9BC202-73B7-4504-BA9A-662AD0C2509A

P2093

Q38209874-33D01FCC-7E64-40DF-AD1C-C4BCAD1CCEE0

Q38209874-3F4E5C65-4D99-4C79-9EA4-9BC681F3692C

Q38209874-C2AD1D05-33D5-465F-9951-AE6704FB39A5

Q38209874-FA652449-0913-4698-BC31-3181F00E14B8

P2860

Q38209874-00E5AF88-D932-4FC9-9F24-D71AD11DD075

Q38209874-0637D11B-A3C7-4760-8CB8-B2B4BE4B1B02

Q38209874-0A015E98-5296-41DE-86D6-ED787955423E

Q38209874-0D451FBB-70DF-46C7-8EF5-DD0E5E12F203

Q38209874-1461AFC5-AF55-4D3E-BFD1-5C37F86AEE42

Q38209874-14E26919-4677-498B-8D2B-A9A60DA76768

Q38209874-151C4521-9CCA-47C8-8A6A-2D1DFA01D976

Q38209874-15421CF5-2BDE-4EB3-98F3-FA643A52E5BD

Q38209874-1797F2F9-28AA-4615-B050-4379A8183B11

Q38209874-18CCA946-5304-47D7-A8DB-F66F71537311

P304

Q38209874-65089BDF-49E9-4513-BE0C-D45B2C3B926E

P31

Q38209874-A8A77A5F-F628-4E6F-A9D1-132796557433

P356

Q38209874-6D3FBD5F-17D2-4530-AD1E-BA76690F0695

P433

Q38209874-4875FC86-A0CE-4C80-B20E-7FFD8201D81B

P478

Q38209874-AE3B441F-3059-4D2E-AB83-1428FD0CC409

P50

Q38209874-35214930-AC24-4EC1-9175-0F4B6F5AD38E

Q38209874-4904674C-D5AE-4EA7-9CFF-2B775F0545C4

P577

Q38209874-00630B70-4A37-4BDC-AA44-34A6EA57A3C1

P5875

Q38209874-13961812-63CD-44D0-BCE8-768980B40A05

P698

Q38209874-B3D5BCE8-D735-4750-861E-C57487BC84B2

P921

Q38209874-94ACB12E-79F0-4B01-9673-81B40340F388

P356

14787210.2014.913981

P1433

Expert Review of Anti-infective Therapy

P1476

Update on antiretroviral treatment during primary HIV infection.

@en

P2093

Christian Manzardo

http://www.w3.org/2001/XMLSchema#string

Fernando Agüero

http://www.w3.org/2001/XMLSchema#string

Jose M Miro

http://www.w3.org/2001/XMLSchema#string

Juan Ambrosioni

http://www.w3.org/2001/XMLSchema#string

P2860

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

Prevention of HIV-1 infection with early antiretroviral therapy

National prevalence and trends of HIV transmitted drug resistance in Mexico

Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe

Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010

HIV-1 genetic diversity and transmitted drug resistance mutations among patients from the North, Central and South regions of Angola

Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.

The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection.

Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment

A randomized open-label study of 3- versus 5-drug combination antiretroviral therapy in newly HIV-1-infected individuals

P304

793-807

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2014.913981

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262108704

http://www.w3.org/2001/XMLSchema#string

P698

24803105

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug